MichaelPerez

    • MichaelPerezMichaelPerez
      ·11-20
      $Circle Internet Corp.(CRCL)$ has successfully built a solid base with significantly higher trading volume, and it's firmly standing at a turning point! Made some decent gains on this move—feeling like it's only a matter of time before it climbs back to $300. Plus, the recent Contra688 event is just awesome—free top-up vouchers really sweetened the holding cost!
      5751
      Report
    • MichaelPerezMichaelPerez
      ·09-22
      $Apple(AAPL)$ 's trend is seriously impressive! Lines for new products at stores, strongest earnings ever incoming. Waiting for the stock to take off, $250 this week is a no-brainer.
      1.32K1
      Report
    • MichaelPerezMichaelPerez
      ·08-22
      $MEITU(01357)$ Solid companies thrive over time. Short-term dips won't stop Meitu's rise. Fundamentals remain strong—waiting for a comeback to new highs!
      1.17KComment
      Report
    • MichaelPerezMichaelPerez
      ·07-18
      $HORIZONROBOT-W(09660)$ Localization accelerates, Horizon Robotics leads the race as a rising star. Having broken the triangle pattern, today's pullback is normal. The gap is likely to be filled next week with all indicators pointing upward.
      1.71K1
      Report
    • MichaelPerezMichaelPerez
      ·06-30
      $ProShares Ultra Semiconductors(USD)$ All in one day! ProShares Ultra Semiconductors delivers a +850.57 USD unrealized gain in just one session! With entry at 69.39 USD and current price 74.16 USD, leveraged semiconductor exposure proves its explosive potential. Another perfectly timed play in the chip revolution—this profit screams market mastery. The tech wave is rising, and I'm riding it to the moon!
      1.67K1
      Report
    • MichaelPerezMichaelPerez
      ·06-05
      $Spdr S&P Biotech Etf(XBI)$ Looking at XBI’s recent moves, it’s clear,being in the biotech game isn’t easy. We’re in a post-immunotherapy era now, where most “innovation” is just patchwork and endless competition. In reality, developing new drugs is an act of faith. Making money in this space? It’s a mix of fate, luck, and catching beta waves. Trying to find alpha from picking individual biotech stocks is hard,even for so-called “pros.” To everyone out there building or betting on innovation in this space: much respect. You deserve support, and some encouragement too.
      2.09K1
      Report
    • MichaelPerezMichaelPerez
      ·05-12
      $JD LOGISTICS(02618)$ Pang Donglai has teamed up with $JD-SW(09618)$ to build a supply chain base, which will be put into production in June, just in time for the 618 shopping festival. Don’t say it’s not interesting. Think about the more than 100 Pang Donglai products that will all be launched on JD.com, with logistics all relying on JD.com, and users across the country placing orders and receiving goods directly. You can imagine the data will soar with your eyes closed. This wave is superimposed on the peak stimulation of flash sales for takeout. In the short term, funds will rush in as soon as they smell the wind. I am optimistic that it will have a beautiful volatile market, and there is nothing wro
      2.19K1
      Report
    • MichaelPerezMichaelPerez
      ·04-11
      $Strategy(MSTR)$ is literally the big short crowd’s top target. If we get hit with a liquidity crisis like March 2020 again, remember when oil futures went negative, MSTR will be the first to crack. That’s why I’m eyeing $T-Rex 2X Inverse MSTR Daily Target ETF(MSTZ)$ . Bottom-fishing this one just makes sense:low resistance, high payoff, perfect play for a shaky market!
      3.03KComment
      Report
    • MichaelPerezMichaelPerez
      ·03-17
      $BABA-W(09988)$ Hold firm and await the upcoming good news! Alibaba has announced plans to invest over 380 billion yuan in the next three years, primarily for cloud computing and AI hardware infrastructure development—an amount larger than the total investment over the past decade. According to the Q3 fiscal 2025 earnings report, Alibaba's revenue grew by 8% year-on-year, operating profit surged by 83%, and net profit skyrocketed by 333%. Alibaba Cloud’s commercial revenue has returned to double-digit growth, while AI-related product revenues have maintained triple-digit growth for six consecutive quarters, showcasing strong momentum and market competitiveness. The future holds enormous growth potential—stay tuned as Alibaba continues to soar!
      2.14KComment
      Report
    • MichaelPerezMichaelPerez
      ·02-11
      $Direxion Daily 20 Year Plus Treasury Bear 3x Shares(TMV)$ Successfully sold my TMV today, gotta say, leveraged ETFs are pretty volatile, but they sure make things exciting! TMV is a 3x inverse ETF on long-term US Treasuries, and recently, US Treasury yields have been on the rise, especially the 10-year yield, which directly boosted TMV's performance. The ongoing Fed rate hikes have also put pressure on the bond market, which worked in TMV's favor. This trade was perfectly timed, and big thanks to CBA for making the process smooth!
      2.73KComment
      Report
     
     
     
     

    Most Discussed